Technical Analysis for CRSP - CRISPR Therapeutics AG
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | -2.86% | |
| Stochastic Buy Signal | Bullish | -2.86% | |
| Oversold Stochastic | Weakness | -2.86% | |
| Calm After Storm | Range Contraction | -2.26% | |
| NR7 | Range Contraction | -2.26% | |
| NR7-2 | Range Contraction | -2.26% | |
| Narrow Range Bar | Range Contraction | -2.26% | |
| Oversold Stochastic | Weakness | -2.26% | |
| 50 DMA Resistance | Bearish | -2.94% | |
| Calm After Storm | Range Contraction | -2.94% |
| Alert | Time |
|---|---|
| Down 3% | 8 minutes ago |
| 1.5x Volume Pace | 27 minutes ago |
| Fell Below Previous Day's Low | 27 minutes ago |
| Down 2 % | 27 minutes ago |
| Down 1% | 27 minutes ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine CRISPR DNA Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine CRISPR DNA Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 91.1 |
| 52 Week Low | 43.42 |
| Average Volume | 1,379,100 |
| 200-Day Moving Average | 57.25 |
| 50-Day Moving Average | 47.99 |
| 20-Day Moving Average | 49.26 |
| 10-Day Moving Average | 49.45 |
| Average True Range | 2.37 |
| RSI (14) | 45.36 |
| ADX | 13.92 |
| +DI | 26.34 |
| -DI | 24.14 |
| Chandelier Exit (Long, 3 ATRs) | 51.95 |
| Chandelier Exit (Short, 3 ATRs) | 52.56 |
| Upper Bollinger Bands | 53.55 |
| Lower Bollinger Band | 44.97 |
| Percent B (%b) | 0.27 |
| BandWidth | 17.43 |
| MACD Line | -0.08 |
| MACD Signal Line | 0.43 |
| MACD Histogram | -0.5157 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 49.21 | ||||
| Resistance 3 (R3) | 49.21 | 48.56 | 48.89 | ||
| Resistance 2 (R2) | 48.56 | 48.06 | 48.56 | 48.78 | |
| Resistance 1 (R1) | 47.91 | 47.76 | 48.24 | 47.91 | 48.67 |
| Pivot Point | 47.26 | 47.26 | 47.42 | 47.26 | 47.26 |
| Support 1 (S1) | 46.61 | 46.76 | 46.94 | 46.61 | 45.85 |
| Support 2 (S2) | 45.96 | 46.46 | 45.96 | 45.74 | |
| Support 3 (S3) | 45.31 | 45.96 | 45.64 | ||
| Support 4 (S4) | 45.31 |
